PMDA — authorised 28 March 2022
- Marketing authorisation holder: Nippon Shinyaku Co., Ltd
- Status: approved
🇯🇵 Monoferric in Japan
PMDA authorised Monoferric on 28 March 2022
Marketing authorisation
Monoferric in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Monoferric approved in Japan?
Yes. PMDA authorised it on 28 March 2022.
Who is the marketing authorisation holder for Monoferric in Japan?
Nippon Shinyaku Co., Ltd holds the Japanese marketing authorisation.